References
- Rick O, Reuß-Borst M, Dauelsberg T, et al. NeuroCog FX study: a multicenter cohort study on cognitive dysfunction in patients with early breast cancer. Psychooncology. 2018;27(8):2016–2022. doi:https://doi.org/10.1002/pon.4763
- Wefel JS, Saleeba AK, Buzdar AU, et al. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer. 2010;116(14):3348–3356. doi:https://doi.org/10.1002/cncr.25098
- Cheung YT, Ng T, Shwe M, et al. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study. Ann Oncol. 2015;26(7):1446–1451. doi:https://doi.org/10.1093/annonc/mdv206
- Mehnert A, Scherwath A, Schirmer L, et al. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Patient Educ Couns. 2007;66(1):108–118. doi:https://doi.org/10.1016/j.pec.2006.11.005
- Von Ah D, Tallman EF. Perceived cognitive function in breast cancer survivors: evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy-cognitive function instrument. J Pain Symptom Manage. 2015;49(4):697–706. doi:https://doi.org/10.1016/j.jpainsymman.2014.08.012
- Vitali M, Ripamonti CI, Roila F, et al. Cognitive impairment and chemotherapy: a brief overview. Crit Rev Oncol Hematol. 2017;118:7–14. doi:https://doi.org/10.1016/j.critrevonc.2017.08.001
- Ganz PA, Kwan L, Castellon SA, et al. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. J Natl Cancer Inst. 2013;105(11):791–801. doi:https://doi.org/10.1093/jnci/djt073
- Von Ah D, Habermann B, Carpenter JS, et al. Impact of perceived cognitive impairment in breast cancer survivors. Eur J Oncol Nurs. 2013;17(2):236–241. doi:https://doi.org/10.1016/j.ejon.2012.06.002
- Henderson FM, Cross AJ, Baraniak AR. A new normal with chemobrain': Experiences of the impact of chemotherapy-related cognitive deficits in long-term breast cancer survivors. Health Psychol Open. 2019;6(1):2055102919832234. doi:https://doi.org/10.1177/2055102919832234
- Klaver KM, Duijts SFA, Engelhardt EG, et al. Cancer-related cognitive problems at work: experiences of survivors and professionals. J Cancer Surviv. 2020;14(2):168–178. doi:https://doi.org/10.1007/s11764-019-00830-5
- Ferguson RJ, Ahles TA, Saykin AJ, et al. Cognitive-behavioral management of chemotherapy-related cognitive change. Psychooncology. 2007;16(8):772–777. doi:https://doi.org/10.1002/pon.1133
- Ferguson RJ, McDonald BC, Rocque MA, et al. Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial. Psychooncology. 2012;21(2):176–186. doi:https://doi.org/10.1002/pon.1878
- Ferguson RJ, Sigmon ST, Pritchard AJ, et al. A randomized trial of videoconference-delivered cognitive behavioral therapy for survivors of breast cancer with self-reported cognitive dysfunction . Cancer. 2016;122(11):1782–1791. doi:https://doi.org/10.1002/cncr.29891
- Hayes SC, Luoma JB, Bond FW, et al. Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther. 2006;44(1):1–25. doi:https://doi.org/10.1016/j.brat.2005.06.006
- Kashdan TB, Rottenberg J. Psychological flexibility as a fundamental aspect of health. Clin Psychol Rev. 2010;30(7):865–878. doi:https://doi.org/10.1016/j.cpr.2010.03.001
- Dehghani-Najvani B. The effect of acceptance and commitment therapy on depression and psychological flexibility in women with breast cancer. Zahedan J Res Med Sci. 2015;17(4):e965. doi: https://doi.org/10.17795/zjrms965.
- Mosher CE, Secinti E, Li R, et al. Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trial. Support Care Cancer. 2018;26 (6):1993–2004. doi:https://doi.org/10.1007/s00520-018-4045-0
- Mojtabaie M, Gholamhosseini S. Effectiveness of acceptance and commitment therapy act to reduce the symptoms of anxiety in women with breast cancer. J Soc Issues Humanities. 2015;3(1):154–157.
- Johns SA, Stutz PV, Talib TL, et al. Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: a 3-arm pilot randomized controlled trial. Cancer. 2020;126(1):211–218. doi:https://doi.org/10.1002/cncr.32518
- Kuba K, Weißflog G, Götze H, et al. The relationship between acceptance, fatigue, and subjective cognitive impairment in hematologic cancer survivors. Int J Clin Health Psychol. 2019;19(2):97–106., doi:https://doi.org/10.1016/j.ijchp.2018.12.001
- Hulbert-Williams NJ, Storey L, Wilson KG. Psychological interventions for patients with cancer: psychological flexibility and the potential utility of Acceptance and Commitment Therapy. Eur J Cancer Care (Engl)). 2015;24(1):15–27. doi:https://doi.org/10.1111/ecc.12223
- Faul F. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods Instrum Comput. 2007;39:175–191.
- Wagner LI, et al. Measuring patient self-reported cognitive function: development of the Functional Assessment of Cancer Therapy–Cognitive Function Instrument. J Supportive Oncol. 2009;7(6):32–39.
- Cheung YT, Lim SR, Shwe M, et al. Psychometric properties and measurement equivalence of the English and Chinese versions of the functional assessment of cancer therapy-cognitive in Asian patients with breast cancer. Value Health. 2013;16(6):1001–1013. doi:https://doi.org/10.1016/j.jval.2013.06.017
- Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi:https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
- Yellen SB, Cella DF, Webster K, et al. Measuring fatigue and other anemia-related symptoms with the functional assessment of cancer therapy (FACT) measurement system. J Pain Symptom Manage. 1997;13(2):63–74. doi:https://doi.org/10.1016/S0885-3924(96)00274-6
- Bond FW, Hayes SC, Baer RA, et al. Preliminary psychometric properties of the Acceptance and Action Questionnaire-II: a revised measure of psychological inflexibility and experiential avoidance. Behav Ther. 2011;42(4):676–688. doi:https://doi.org/10.1016/j.beth.2011.03.007
- Shari NI, Zainal NZ, Guan NC, et al. Psychometric properties of the acceptance and action questionnaire (AAQ II) Malay version in cancer patients. PloS One. 2019;14(2):e0212788. doi:https://doi.org/10.1371/journal.pone.0212788
- Kohtala A, Lappalainen R, Savonen L, et al. A four-session acceptance and commitment therapy based intervention for depressive symptoms delivered by masters degree level psychology students: a preliminary study. Behav Cogn Psychother. 2015;43(3):360–373. doi:https://doi.org/10.1017/S1352465813000969
- Cheung YT, Foo YL, Shwe M, et al. Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: cognitive function (FACT-Cog) in breast cancer patients. J Clin Epidemiol. 2014;67(7):811–820. doi:https://doi.org/10.1016/j.jclinepi.2013.12.011
- Collins B, Mackenzie J, Kyeremanteng C. Study of the cognitive effects of chemotherapy: considerations in selection of a control group. J Clin Exp Neuropsychol. 2013;35(4):435–444. doi:https://doi.org/10.1080/13803395.2013.781995
- Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York: Routledge Academic; 1988.
- Hayes AF, Rockwood NJ. Regression-based statistical mediation and moderation analysis in clinical research: Observations, recommendations, and implementation. Behav Res Ther. 2017;98:39–57. doi:https://doi.org/10.1016/j.brat.2016.11.001
- Hayes AF, Preacher KJ. Statistical mediation analysis with a multicategorical independent variable. Br J Math Stat Psychol. 2014;67(3):451–470. doi:https://doi.org/10.1111/bmsp.12028
- Shrout PE, Bolger N. Mediation in experimental and nonexperimental studies: new procedures and recommendations. Psychol Methods. 2002;7(4):422–445. doi:https://doi.org/10.1037/1082-989X.7.4.422
- Cheung YT, Shwe M, Tan YP, et al. Cognitive changes in multiethnic Asian breast cancer patients: a focus group study. Ann Oncol. 2012;23(10):2547–2552. doi:https://doi.org/10.1093/annonc/mds029
- Feros DL, Lane L, Ciarrochi J, et al. Acceptance and Commitment Therapy (ACT) for improving the lives of cancer patients: a preliminary study. Psychooncology. 2013;22(2):459–464. doi:https://doi.org/10.1002/pon.2083
- Rost AD, Wilson K, Buchanan E, et al. Improving psychological adjustment among late-stage ovarian cancer patients: examining the role of avoidance in treatment. Cognit Behav Pract. 2012;19(4):508–517. doi:https://doi.org/10.1016/j.cbpra.2012.01.003
- Dindo L, Van Liew JR, Arch JJ. Acceptance and commitment therapy: a transdiagnostic behavioral intervention for mental health and medical conditions. Neurotherapeutics. 2017;14(3):546–553. doi:https://doi.org/10.1007/s13311-017-0521-3
- Aguirre-Camacho A, Pelletier G, González-Márquez A, et al. The relevance of experiential avoidance in breast cancer distress: insights from a psychological group intervention. Psychooncology. 2017;26(4):469–475. doi:https://doi.org/10.1002/pon.4162
- Hayes S, Strosahl K, Wilson K. In Acceptance and Commitment Therapy: An Experiential Approach to Behavior Change. New York: Guilford Press; 1999.
- Hubbard NA, Hutchison JL, Turner M, et al. Depressive thoughts limit working memory capacity in dysphoria. Cogn Emot. 2016;30(2):193–209. doi:https://doi.org/10.1080/02699931.2014.991694
- Svendsen JL, Kvernenes KV, Wiker AS, et al. Mechanisms of mindfulness: Rumination and self-compassion. Nord Psychol. 2017;69(2):71–82. doi:https://doi.org/10.1080/19012276.2016.1171730
- Hofman M, Ryan JL, Figueroa‐Moseley CD, et al. Cancer-related fatigue: the scale of the problem. Oncologist. 2007;12(S1):4–10. doi:https://doi.org/10.1634/theoncologist.12-S1-4